Israeli startup Cell-El Therapeutics.is developing a diagnostic tool for “triple A” (autoimmune antibody associated) autism. It has identified 30 immunological biomarkers and is developing a blood test using the best five. This could help identify severely autistic children and implement early therapies.
https://www.israel21c.org/a-diagnostic-tool-that-treats-autism-like-cancer/